en

KATP channel blocker to treat glaucoma

Paper: Tolbutamide Eye Drops Increase Aqueous Humor Outflow and Lower Intraocular Pressure: A Proof-of-Concept for Glaucoma Treatment

    Organizational unit
    Experimental Ophthalmology Group
    Type
    Dataset
    DOI
    10.26037/yareta:rfnal7rkpzamzpcglubitcct6a
    License
    Creative Commons Attribution 4.0 International
    Keywords
    KATP channels glaucoma tolbutamide proof-of-concept case-series
Publication date26/04/2021
Retention date
accessLevelPublicAccess levelPublic
SensitivityBlue
duaNoneContract on the use of data
Contributors
  • Thumann, Gabriele
  • Lorincz, Erika
  • Lorincz, Erika
11
0
  • Quality (0 Reviews)
  • Usefulness (0 Reviews)

Datacite metadata

Packages information

Similar archives

Experimental Ophthalmology Group
SNF2016 project (31003A_160195/1)
2021 accessLevelPublic Public 8.5 MB
Experimental Ophthalmology Group
SNF2019 project (310030_182788/6)
2020 accessLevelPublic Public 54.6 MB
All rights reserved by DLCM and the University of GenevaunigeBlack